Apollo Hospitals Enterprise share news, announcements and annual reports
NSE: APOLLOHOSPBSE: 508869Healthcare ServicesLarge Cap
Apollo Hospitals Enterprise Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 1983 on BSE, Jan 1996 on NSE
Last close ₹8,448.00up ₹248.00 (3.02%)BSE ₹8,400.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹8,200.00.
30 Oct: open ₹8,195.00, high ₹8,448.00, low ₹8,176.00
52-week range of traded prices to 30 Oct 2026
₹6,696.50Low, 23 Jan 2026₹9,070.50High, 23 Sep 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,21,469 Cr97th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 58.13
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 12.81
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.24%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 23.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 19.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.57
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,72,15658.2% delivered
Apollo Hospitals Enterprise share news and announcements
863 announcements, routine notices left out, newest first. Page 15 of 18.
Jul 2012
20 Jul · Board meeting
To consider inter-alia, approve and take on record unaudited financial results of the company for the quarter ended June 30, 2012.
Jun 2012
8 Jun · Meeting
Register of Members and Share Transfer Registers shall remain closed from July 28, 2012 to August 09, 2012, (both days inclusive) for the purpose of determining the names of the shareholders who are entitled for the dividend and also for the purpose of Annual General Meeting to be held on August 09, 2012.
May 2012
29 May · Dividend
Board of Directors of the Company at its meeting held on May 29, 2012 has recommended a dividend of Rs. 4.00 per share (80% of the face value of the share) for the financial year ended March 31, 2012, on the paid up equity capital of the Company. The dividend, if declared, will be paid on or before August 22, 2012.14 May · Board meeting
To consider inter alia :- (1) The Audited Financial Results of the Company for the year ended March 31, 2012; (2) The Audited Consolidated Financial Results of the Company and its subsidiaries, Joint Ventures and Associate Companies for the year ended March 31, 2012; (3) To recommend a dividend, if any, for the financial year ended March 31, 2012.
Apr 2012
19 Apr · Results
Company has opted to submit the Audited Financial Results for the year ended March 31, 2012 within the time limit of sixty days from the end of the financial year i.e., on or before May 30, 2012. In view of this, the Company does not propose to publish the unaudited financial results for the last quarter ended March 31, 2012.
Mar 2012
13 Mar · Updates
On March 12, 2012, Apax Partners transferred their entire holding in the Company of 17,042,126 equity shares (representing 12.67% of company's total shareholding) held by Apax Mauritius FDI One Ltd (14,094,238 equity shares) and Apax Mauritius FII Ltd (2,947,888 equity shares) to its Group Affiliate, HSTN Acquisition (FII) Ltd. This represents an inter-se transfer within their funds as advised by Apax Partners and was done through block deal transactions on the stock exchange. HSTN Acquisition (FII) Ltd will hold 13,446,657 equity shares (representing 10% of company's total shareholding) as direct equity investment in the Company and the balance 3,595,469 shares (representing 2.67% of company's total shareholding) in the form of GDRs which were acquired pursuant to the two way fungibility scheme.
Feb 2012
Jan 2012
19 Jan · Board meeting
To consider inter alia, approve and take on record unaudited financial results of the Company for the quarter/nine months ended December 31, 2011.5 Jan · News Verification
News Verification : The media had reports that Apollo Hospitals Enterprise Limited. is in talks with Parkway Holdings, a Singapore-based hospital operator, on a prospective tie-up for domestic and overseas expansion. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Apollo Hospitals Enterprise Limited has vide its letter inter-alia stated, "Parkway Holdings is controlled by Khazanah Nasional, Malaysia. Khazanah Nasional, through Integrated (Mauritius) Healthcare Holdings Limited (IHHL) holds 11.22% equity stake in Apollo Hospitals Enterprise Ltd. Further, as part of its business Initiatives, the Company and Khazanah Nasional keep discussing various engagements models to further their respective healthcare delivery objectives. There is no specific development that the Company has to share at the current point in time."
Dec 2011
15 Dec · Updates
The Company has got a few enquiries with regard to the recent allotment of 3,089,242 Equity shares of Rs. 5/- each to Dr. Prathap C. Reddy, one of the promoters of the Company, at a price of Rs. 385.88 per share on December 10, 2011. The Company would like to clarify that this allotment is on conversion of warrants issued to Dr. Prathap C. Reddy on June 12, 2010 as per the SEBI formula at the then prevalent Market price and obtaining requisite shareholder approval. As per the SEBI rule, 25% of the value of the warrants was received on June 11, 2010, prior to the warrant allotment and the said warrants were convertible into equity shares within a period of 18 months from the date of allotment of warrants i.e. on or before December 11, 2011. On December 10, 2011, on exercise of the warrants by Dr Prathap C Reddy and receipt of the balance 75% consideration, the shares were allotted by the share allotment committee. In furtherance of the process of consolidating promoter holdings in their own investment Company, PCR Investments Limited which is a part of the promoter group, Dr. Prathap C. Reddy made a inter se transfer of 10,30,000 shares on December 08, 2011 to PCR Investments Limited.12 Dec · Business
Pursuant to the approval of members at the Extraordinary General Meeting held on May 29, 2010, the Company had issued and allotted 1,544,621 share warrants to Dr. Prathap C. Reddy, one of the promoters of the Company on June 12, 2010, with each warrant convertible into one equity share of the Company of nominal value of Rs. 10/- each at a price of Rs. 771.76 which Includes premium of Rs. 761.76 per share calculated in accordance with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2009. The said warrants were convertible into equity shares within a period of 18 months from the date of allotment of warrants i.e., on or before December 11, 2011. The Company obtained the members approval for effecting a stock split in the face value of the equity shares from Rs. 10/- each to Rs. 5/- each, The stock split was effected from September 03, 2010 onwards. Pursuant to the terms of the Issue, 1,544,621 warrants allotted to Dr. Prathap C. Reddy and the corresponding issue price of Rs. 771.76 stood adjusted accordingly as 3,089,242 warrants of face value of Rs. 5/- each at a price of Rs. 385.88 including premium of Rs. 380.88 per share. Further, the Company has Informed that the Share Allotment Committee met on December 10, 2011 and approved the allotment of 3,089,242 equity shares of face value of Rs. 5/- each at a price of Rs. 385.88 per share to Dr. Prathap C. Reddy, promoter of the Company. Further, the Company note that consequent to the above allotment, the paid up share capital of the Company has been increased to Rs. 672,333,090/- (consisting of 134,466,618 equity shares of Rs. 5/- each) from Rs. 656,886,880/- (consisting of 131,377,376 equity shares of Rs. 5/- each).9 Dec · Board meeting
Pursuant to the approval of members at the Extraordinary General Meeting held on May 29, 2010, the Company had issued and allotted 1,544,621 share warrants to Dr. Prathap C Reddy, one of the promoters of the Company on June 12, 2010, with each warrant convertible into one equity share of the Company of nominal value of Rs.10/- each at a price of Rs.771.76 which includes premium of Rs.761.76 per share calculated in accordance with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2009. The said warrants shall be convertible into equity shares within a period of 18 months from the date of allotment of warrants i.e., on or before December 11, 2011.The Company obtained the members approval for effecting a stock split in the face value of the equity shares from Rs.10/- each to Rs.5/- each. The stock split was effected from September 03, 2010 onwards. Pursuant to the terms of the issue, 1,544,621 warrants allotted to Dr. Prathap C Reddy and the corresponding issue price of Rs.771.76 shall stand adjusted accordingly as 3,089,242 warrants of face value of Rs.5/- each at a price of Rs.385.88 including premium of Rs.380.88 per share. Further note that the Meeting of the Share Allotment Committee is scheduled to be held on December 10, 2011, to approve, issue and allot 3,089,242 equity shares of Rs.5/- each at a price of Rs. 385.88 per share to Dr. Prathap C Reddy, promoter of the company, upon conversion of share warrants allotted to him on June 12, 2010.5 Dec · Legal
Spurt in Volume : Substantial increase in trading volumes have been observed in Apollo Hospitals Enterprise Limited.The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Apollo Hospitals Enterprise Limited has vide its letter inter-alia stated,"There is no information/announcement (including pending announcements) which could have a bearing on the price/ volume behavior in our scrip."
Nov 2011
Oct 2011
17 Oct · Board meeting
Inter alia, to consider, approve and take on record unaudited financial results of the Company for the quarter and half year ended September 30, 2011.
Aug 2011
10 Aug · Results
Standalone Results for the quarter ended on 30-JUN-2011 as follows: Net Sales of Rs. 64101 lacs for quarter ending on 30-JUN-2011 against Rs. 52329 lacs for the quarter ending on 30-JUN-2010. Net Profit / (Loss) of Rs. 5127 lacs for the quarter ending on 30-JUN-2011 against Rs. 3927 lacs for the quarter ending on 30-JUN-2010.10 Aug · Results
Jul 2011
26 Jul · Board meeting
Inter alia, to consider, approve and take on record unaudited financial results of the Company for the quarter ended June 30, 2011.
May 2011
26 May · Board meeting
Based on the recommendation of the Remuneration & Nomination Committee, the Board at its meeting held on May 24, 2011 approved the re-designation of Ms. Suneeta Reddy as Joint Managing Director with effect from June 01, 2011 on a remuneration of 1.50% of the net profits of the Company (for the period from June 01, 2011 to February 02, 2016) subject to approval of the members at the ensuing Annual General Meeting.24 May · Meeting
Register of Members and Share Transfer Registers shall remain closed from July 09, 2011, to July 22, 2011, (both days inclusive) for the purpose of determining the names of the shareholders who are entitled for the dividend and also for the purpose of Annual General Meeting to be held on July 22, 2011.24 May · Dividend
Board of Directors of the Company, at their meeting held on May 24, 2011 have recommended a dividend of Rs. 3.75 per share on the equity capital of the Company of Rs.623,553,550/- consisting of 124,710,710 equity shares of face value of Rs.5/- each for the financial year ended March 31, 2011. The dividend, if declared, will be paid on or before August 05, 2011.24 May · Results
Consolidated Results for the year ended on 31-MAR-2011 as follows: Net Sales of Rs. 260535 lacs for year ending on 31-MAR-2011 against Rs. 202647 lacs for the year ending on 31-MAR-2010. Net Profit / (Loss) of Rs. 18392 lacs for the year ending on 31-MAR-2011 against Rs. 13757 lacs for the year ending on 31-MAR-2010.24 May · Results
Standalone Results for the year ended on 31-MAR-2011 as follows: Net Sales of Rs. 233196 lacs for year ending on 31-MAR-2011 against Rs. 182578 lacs for the year ending on 31-MAR-2010. Net Profit / (Loss) of Rs. 18172 lacs for the year ending on 31-MAR-2011 against Rs. 15197 lacs for the year ending on 31-MAR-2010.11 May · Board meeting
To consider inter alia :- (1)The Audited Financial Results of the Company for the year ended March 31, 2011; (2) The Audited Consolidated Financial Results of the Company and its subsidiaries, Joint Ventures and Associate Companies for the year ended March 31, 2011; (3) To recommend a dividend, if any, for the financial year ended March 31, 2011.
Apr 2011
13 Apr · Results
Company has opted to submit the Audited Financial Results for the year ended March 31, 2011 within the time limit of sixty days from the end of the financial year i.e., on or before May 30, 2011. In view of this, the Company does not propose to publish the unaudited financial results for the last quarter ended March 31, 2011.
Feb 2011
11 Feb · Management
Board of Directors of the Company at its meeting held on February 11, 2011 have informed that Mr. Steven Thompson has resigned from the position of Director of the Company due to his inability to continue in view of increased professional commitments.11 Feb · Results
Standalone Results for the quarter ended on 31-DEC-2010 as follows: Net Sales of Rs. 60087 lacs for quarter ending on 31-DEC-2010 against Rs. 48087 lacs for the quarter ending on 31-DEC-2009. Net Profit / (Loss) of Rs. 4581 lacs for the quarter ending on 31-DEC-2010 against Rs. 4391 lacs for the quarter ending on 31-DEC-2009.7 Feb · Business
Committee of Board of Directors at its meeting held on February 05, 2011 approved the allotment of 3,276,922 Warrants convertible into equity shares to Dr. Prathap C Reddy, with each warrant convertible into one equity share of the Company of nominal value of Rs.5/- each at a price of Rs.472.46 which includes a premium of Rs.467.46 per share. The warrants shall be convertible into equity shares at any time within 18 months from the date of allotment.5 Feb · Board meeting
Committee is meeting on February 5, 2011 to consider and approve the allotment of 3,276,922 warrants convertible into equity shares to Dr. Prathap C Reddy pursuant to the special resolution approved by the members at the EGM held on January 22, 2011.